1. U.S. Department of Health and Human Services, Food and Drug Administration. Guidance for industry: Patient-reported outcomes measures: Use in medical product development to support labeling claims. December 2009. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf (last accessed January 21, 2016).
2. Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related Symptoms;Kluetz;Clin Cancer Res,2016
3. The missing voice of patients in drug-safety reporting;Basch;N Engl J Med,2010
4. National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. NIH publication # 09-7473. Published May 29, 2009; Revised Version 4.03 June 14, 2010. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. (last accessed March 16, 2015).
5. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials;Di Maio;J Clin Oncol,2015